Adimab, LLC

Insider Reports History

Entity
Company
Location
7 Lucent Drive, Lebanon, NH
Signature
By: /s/ Philip Chase, Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adimab, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Invivyd, Inc. 10%+ Owner Common Stock 21.7M $85.7M $3.95 Jan 19, 2024 Direct

Insider Reports Filed by Adimab, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IVVD Invivyd, Inc. Jan 19, 2024 1 -$19.8M 4 Jan 22, 2024 10%+ Owner
IVVD Adagio Therapeutics, Inc. Mar 3, 2022 1 $0 4 Apr 1, 2022 Other*, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 10, 2021 4 $0 4 Aug 12, 2021 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 10%+ Owner